Cancer/Tumor Profiling Market Worth 8.74 Billion USD by 2022
The report "Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022", is projected to reach USD 8.74 Billion by 2022 from USD 5.26 Billion in 2017, at a CAGR of 10.7%. Major factors fueling the growth of the market include increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer...
View full press release